Total Payments
$76,078
2024 Payments
$32,164
Companies
55
Transactions
1,434
Medicare Patients
4,346
Medicare Billing
$640,652
Payment Breakdown by Category
Other$49,560 (65.1%)
Food & Beverage$20,351 (26.8%)
Travel$4,705 (6.2%)
Consulting$1,250 (1.6%)
Gifts$129.86 (0.2%)
Education$81.51 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,560 | 22 | 61.2% |
| Food and Beverage | $20,351 | 1,365 | 26.8% |
| Travel and Lodging | $4,705 | 25 | 6.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,000 | 1 | 3.9% |
| Consulting Fee | $1,250 | 1 | 1.6% |
| Gift | $129.86 | 10 | 0.2% |
| Education | $81.51 | 6 | 0.1% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$76,078
1,430 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $25,380 | 49 | $0 (2024) |
| GENZYME CORPORATION | $16,082 | 25 | $0 (2024) |
| Allergan Inc. | $11,141 | 63 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $4,816 | 19 | $0 (2017) |
| ABBVIE INC. | $4,735 | 378 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,939 | 186 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,681 | 119 | $0 (2024) |
| Ardelyx, Inc. | $1,603 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $1,427 | 94 | $0 (2024) |
| Gilead Sciences, Inc. | $694.18 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32,164 | 255 | GENZYME CORPORATION ($15,962) |
| 2023 | $16,105 | 194 | Regeneron Healthcare Solutions, Inc. ($13,633) |
| 2022 | $2,642 | 190 | ABBVIE INC. ($509.11) |
| 2021 | $2,766 | 203 | AbbVie Inc. ($684.29) |
| 2020 | $2,240 | 180 | AbbVie Inc. ($789.06) |
| 2019 | $3,216 | 166 | Allergan Inc. ($1,491) |
| 2018 | $1,913 | 118 | Allergan Inc. ($534.20) |
| 2017 | $15,031 | 128 | Allergan Inc. ($9,116) |
All Payment Transactions
1,434 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Diagnostics | ||||||
| 12/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/23/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $2.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.66 | General |
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $33.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.42 | General |
| 12/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $17.41 | General |
| Category: Elastography | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.52 | General |
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,129 | 11,806 | $1.1M | $309,023 |
| 2022 | 12 | 1,036 | 1,209 | $532,568 | $116,778 |
| 2021 | 16 | 1,071 | 1,274 | $463,936 | $112,583 |
| 2020 | 16 | 1,110 | 1,298 | $425,486 | $102,268 |
Total Patients
4,346
Total Services
15,587
Medicare Billing
$640,652
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 12 | 10,500 | $535,500 | $181,620 | 33.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 124 | 124 | $137,392 | $26,037 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 324 | $52,812 | $21,963 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 160 | 212 | $51,940 | $19,321 | 37.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 172 | 172 | $160,992 | $17,761 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $30,504 | $8,424 | 27.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 45 | 45 | $34,830 | $8,127 | 23.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 110 | 114 | $70,680 | $7,859 | 11.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $14,278 | $4,546 | 31.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 18 | 18 | $13,932 | $3,255 | 23.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 29 | 29 | $18,328 | $2,854 | 15.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 36 | $6,336 | $2,232 | 35.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 14 | 37 | $5,412 | $1,952 | 36.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $7,860 | $1,221 | 15.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 22 | $1,496 | $955.17 | 63.8% |
| 45331 | Biopsy of lower large bowel using a flexible endoscope | Facility | 2023 | 16 | 17 | $4,607 | $895.68 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 315 | $71,460 | $30,030 | 42.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 120 | 120 | $123,288 | $23,107 | 18.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 168 | 168 | $150,062 | $16,399 | 10.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 180 | 235 | $35,653 | $15,239 | 42.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 114 | 114 | $38,682 | $13,310 | 34.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 109 | 111 | $68,062 | $7,151 | 10.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 22 | 22 | $16,789 | $3,951 | 23.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $8,808 | $3,074 | 34.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 21 | 21 | $9,211 | $1,991 | 21.6% |
About Dr. Jonathan Fishman, MD
Dr. Jonathan Fishman, MD is a Gastroenterology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104813559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Fishman, MD has received a total of $76,078 in payments from pharmaceutical and medical device companies, with $32,164 received in 2024. These payments were reported across 1,434 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($46,560).
As a Medicare-enrolled provider, Fishman has provided services to 4,346 Medicare beneficiaries, totaling 15,587 services with total Medicare billing of $640,652. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Denver, CO
- Active Since 09/30/2005
- Last Updated 02/14/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1104813559
Products in Payments
- DUPIXENT (Biological) $41,462
- LINZESS (Drug) $10,472
- UCERIS (Drug) $4,664
- IBSRELA (Drug) $1,603
- HUMIRA (Biological) $1,200
- STELARA (Biological) $1,157
- Humira (Biological) $1,083
- XIFAXAN (Drug) $1,042
- ENTYVIO (Biological) $917.29
- RINVOQ (Biological) $801.73
- TRULANCE (Drug) $795.82
- XELJANZ (Drug) $627.47
- ZEPOSIA (Drug) $579.92
- VIBERZI (Drug) $564.28
- Entyvio (Biological) $418.52
- RENFLEXIS (Drug) $403.34
- MAVYRET (Drug) $386.26
- ZENPEP (Drug) $354.62
- OMVOH (Drug) $344.01
- CREON (Drug) $286.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Denver
Mary Ann Huang, M.d, M.D
Gastroenterology — Payments: $557,422
Gastroenterology $557,422
Pranav Periyalwar, M.d, M.D
Gastroenterology — Payments: $156,722
Gastroenterology $156,722
Dr. Joseph Chang, Md, MD
Gastroenterology — Payments: $23,541
Gastroenterology $23,541
Kevin Sieja, M.d, M.D
Gastroenterology — Payments: $10,769
Gastroenterology $10,769
Julie Polson, Md, MD
Gastroenterology — Payments: $9,020
Gastroenterology $9,020
Kevin Rufner, Md, Mph, MD, MPH
Gastroenterology — Payments: $8,586
Gastroenterology $8,586